drugset / Trial / NCT05352542
GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
A Phase I Clinical Trial for Evaluating the Safety, Tolerance and Efficacy of GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma
Timeline
- Start
- 2022-05-19
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
Outcome
Outcome not reported
Stopped: “achieve the proof of concept”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GPC3 Targeting CART Cells | Cell therapy | — | — |